MarketCap
OptimizeRx Corporation OPRX
$ 8.65
-0.12%
Facebook
X
Telegram
OptimizeRx Corporation Cash Conversion Cycle | OPRX
Annual Cash Conversion Cycle OptimizeRx Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107 | 123 | 125 | 120 | 118 | 96.1 | 25.9 | 17.1 | -19.8 | -176 | -172 | -140 | -288 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 125 | -288 | -4.79 |
Quarterly Cash Conversion Cycle OptimizeRx Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 93.6 | 80.3 | 118 | - | 75.6 | 102 | 129 | - | 10.6 | 3.67 | -0.18 | - | 3.76 | 4.43 | 6.61 | - | -4.63 | 42.8 | 50.2 | - | 65.4 | 77.8 | 137 | - | 113 | 79.9 | 95.5 | - | 92.3 | 98.8 | 142 | - | 66.4 | 71.9 | 110 | - | 156 | 146 | 123 | - | 129 | 152 | 152 | - | 84 | 134 | 128 | - | 19.5 | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 156 | -4.63 | 83.5 |
Cash Conversion Cycle of other stocks in the Health information services industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
84.9 | $ 11.95 | -1.24 % | $ 192 M |  USA |
 |
Evolent Health
EVH
|
6.72 | $ 4.58 | 0.77 % | $ 523 M | USA |
 |
GoodRx Holdings
GDRX
|
-18.9 | $ 3.52 | 0.86 % | $ 1.25 B | USA |
 |
Castlight Health, Inc.
CSLT
|
68.7 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
-587 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
56.1 | - | - | $ 6.37 B | USA |
 |
Health Catalyst
HCAT
|
47.4 | $ 1.47 | -2.0 % | $ 103 M | USA |
 |
HealthEquity
HQY
|
21.5 | $ 103.6 | 0.13 % | $ 8.92 B | USA |
 |
Omnicell
OMCL
|
98 | $ 37.35 | -1.77 % | $ 1.72 B | USA |
 |
Progyny
PGNY
|
36.4 | $ 34.88 | 1.48 % | $ 2.97 B | USA |
 |
Teladoc Health
TDOC
|
28.2 | $ 8.85 | -6.2 % | $ 1.56 B | USA |
 |
Computer Programs and Systems
CPSI
|
19.6 | - | 4.4 % | $ 133 M | USA |
 |
Phreesia
PHR
|
21.2 | $ 12.62 | -0.71 % | $ 754 M | USA |
 |
Akerna Corp.
KERN
|
-12.7 | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
22.1 | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
110 | - | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | USA |
 |
Signify Health
SGFY
|
214 | - | -0.02 % | $ 7.21 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
12 | - | - | $ 255 M | USA |
 |
Change Healthcare
CHNG
|
76.2 | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
-20 | - | - | $ 27.9 B | USA |
 |
So-Young International
SY
|
95.5 | $ 2.07 | -1.2 % | $ 161 M |  China |
 |
Veeva Systems
VEEV
|
114 | $ 303.83 | -2.03 % | $ 49.7 B | USA |
 |
SCWorx Corp.
WORX
|
43.5 | $ 7.25 | 31.34 % | $ 52.7 M | USA |
 |
Zhongchao
ZCMD
|
82.2 | $ 0.96 | -0.08 % | $ 3.28 M | China |
 |
HealthStream
HSTM
|
26.7 | $ 28.84 | -1.76 % | $ 866 M | USA |
 |
Accolade
ACCD
|
0.3 | - | 0.29 % | $ 206 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
34.6 | - | -10.39 % | $ 886 M | USA |
 |
NantHealth
NH
|
-54.1 | - | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
52.1 | - | - | $ 2.94 B | USA |
 |
NextGen Healthcare
NXGN
|
34.7 | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
33.8 | - | - | $ 3.37 B | USA |
 |
iCAD
ICAD
|
117 | - | - | $ 102 M | USA |
 |
R1 RCM
RCM
|
21.9 | - | - | $ 3.81 B | USA |
 |
10x Genomics
TXG
|
143 | $ 58.86 | 1.38 % | $ 7.34 B | USA |